Home Biosimilar Antibodies Metabolism Carbonic Anhydrase antibody Girentuximab (Anti-CA9 / Carbonic anhydrase 9) For research use only.
Not for use in humans.

Girentuximab (Anti-CA9 / Carbonic anhydrase 9)

Synonyms: G250; cG250

Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). MW:145.5 KD.

Girentuximab (Anti-CA9 / Carbonic anhydrase 9)

Purity & Quality Control

Batch: A257801 Purity: 99% Protein concentration: 7.98mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Carbonic Anhydrase Inhibitors

Biological Activity

Description Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). MW:145.5 KD.

Product Details

CAS No. 916138-87-9
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Girentuximab (Anti-CA9 / Carbonic anhydrase 9) | Girentuximab (Anti-CA9 / Carbonic anhydrase 9) supplier | purchase Girentuximab (Anti-CA9 / Carbonic anhydrase 9) | Girentuximab (Anti-CA9 / Carbonic anhydrase 9) cost | Girentuximab (Anti-CA9 / Carbonic anhydrase 9) manufacturer | order Girentuximab (Anti-CA9 / Carbonic anhydrase 9) | Girentuximab (Anti-CA9 / Carbonic anhydrase 9) distributor